COMMUNIQUÉS West-GlobeNewswire

Imaging3 Engages Renowned MZ Group to Expand Investor Awareness and Shareholder Communication Program
05/04/2018
BURBANK, Calif., April 05, 2018 (GLOBE NEWSWIRE) -- Imaging 3 , Inc. (OTCQB:IGNGD), a development stage company introducing disruptive technologies in the medical imaging industry, has engaged MZ Group, a leading [...]
Zecotek Provides Update for Zecotek Imaging China
05/04/2018
VANCOUVER, British Columbia, April 05, 2018 (GLOBE NEWSWIRE) -- Zecotek Photonics Inc. (“ Zecotek ” or the “ Company ”) (TSX-V: ZMS ) (Frankfurt: W1I ) (OTCPK:ZMSPF), a developer of leading-edge photonics technologies [...]
Progressive Care: S. Mars, CEO Releases Open Letter to Shareholders
05/04/2018
MIAMI, April 05, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, releases open letter to shareholders written by the Company’s CEO, S. Parikh Mars. Dear [...]
ICC Labs Announces New Initiative to Conduct Various Scientific and Medicinal Research Activities
05/04/2018
VANCOUVER, British Columbia, April 05, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ ICC Labs ” or the “ Company ”) (TSX-V: ICC ) (Frankfurt: 2Q9 ) is pleased to announce that it and one of its Uruguayan subsidiaries have [...]
Aeglea BioTherapeutics to Present Pegzilarginase Phase 1 Dose Escalation Data in Patients with Advanced Solid Tumors at 2018 AACR Annual Meeting
05/04/2018
AUSTIN, Texas, April 05, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with [...]
BioSig Technologies Issues 2018 Shareholder Letter
05/04/2018
Highlights Include FDA 510(k) Submission and Insider Buying Santa Monica, CA, April 05, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ( BSGM ) a medical device company developing a proprietary biomedical signal [...]
PhaseBio Announces Completion of Dosing in First Cohort of Phase 1 Clinical Trial of PB2452, a Reversal Agent for Ticagrelor
05/04/2018
MALVERN, Pa., April 05, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing therapies for the treatment of orphan diseases, today announced that it has [...]
HempAmericana Files Permits for Licensed Grower Status as High-Capacity CBD Oil Operation Nears Full-Scale Production
05/04/2018
NEW YORK, April 05, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is excited to announce that the Company has filed permits to become a licensed grower in [...]
Cue Biopharma to Present at Bloomberg Biotech Innovations Conference
05/04/2018
CAMBRIDGE, Mass., April 05, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ: CUE ) an immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune [...]
Theratechnologies Announces Financial Results for First Quarter of 2018
05/04/2018
MONTREAL, April 05, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH ) today announced its financial results for the first quarter ended February 28, 2018. First quarter 2018 financial [...]
Theratechnologies annonce ses résultats financiers du premier trimestre de 2018
05/04/2018
MONTRÉAL, 05 avr. 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX: TH ) a annoncé aujourd’hui ses résultats financiers pour le premier trimestre clos le 28 février 2018. Faits saillants [...]
VitalHub Announces Listing on Frankfurt Stock Exchange
05/04/2018
TORONTO, April 05, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV:VHI) is pleased to announce that as of the beginning of April 2018, the Company has listed on the Frankfurt Stock Exchange [...]
BioCorRx Partner, Virtual Reality Medical Center, Submits Small Business Innovation Grant Application to the National Institute of Health
05/04/2018
ANAHEIM, CA, April 05, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that its [...]
Evolus Phase III European - Canadian Head-to-Head Trial of prabotulinumtoxinA Compared to Botox® Meets Primary Endpoint
05/04/2018
Results presented today at 2018 Aesthetic and Anti-Aging Medicine World Congress (AMWC) IRVINE, Calif., April 05, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS ) (“Evolus”), a medical aesthetics company focused on [...]
DiaMedica Therapeutics Announces Appointment of Scott Kellen as Chief Financial Officer
05/04/2018
MINNEAPOLIS, April 05, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “ Company ”) (TSX-V: DMA ) (OTCQB:DMCAF) is pleased to announce the appointment of Mr. Scott Kellen as Chief Financial Officer and [...]
Sonoma Pharmaceuticals Announces FDA Approval for Antimicrobial Post-Therapy Gel
05/04/2018
PETALUMA, Calif., April 05, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, warrants SNOAW), a specialty pharmaceutical company that develops and markets unique and effective solutions for [...]
Summit Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
05/04/2018
Summit Therapeutics plc ("Summit", or the "Company") Summit Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference Oxford, UK, and Cambridge, MA, US, 5 April 2018 - Summit Therapeutics plc ( [...]
Summit Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
05/04/2018
OXFORD, United Kingdom, and CAMBRIDGE, Mass., April 05, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM) announces that Glyn Edwards, Chief Executive Officer, will present at the H.C. [...]
Antares Pharma Provides XYOSTED™ Regulatory Update
05/04/2018
Complete Response Resubmission Accepted – PDUFA Date September 29, 2018 EWING, N.J., April 05, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) (the Company) today announced that the U.S. Food and Drug [...]

Pages